# PAI Pharma Acquires Nexus for Hospital Products

> PAI Pharma adds 20+ hospital injectables via Nexus acquisition.
- Title: PAI Pharma Acquires Nexus for Hospital Products · Pulse 2.0
- Summary: PAI Pharma adds 20+ hospital injectables via Nexus acquisition. PAI Pharma acquired Nexus Pharmaceuticals to expand its hospital injectable product portfolio.
- Keywords: pai pharma, nexus pharmaceuticals, hospital injectable products, acquisition, pharmaceuticals, critical care, oncology, sterile pharmaceuticals, aseptic manufacturing, sacramento, olympus partners, nivagen
- Source: Pulse 2.0 — https://pulse2.com/pai-pharma-nexus-pharmaceuticals-acquisition-adds-over-20-hospital-injectable-products
- Author: Amit Chowdhry
- Published: 2026-11-13T18:28:58+00:00
- Read time: 1 min
- Topics: pai pharma, nexus pharmaceuticals, hospital injectable products, acquisition, pharmaceuticals, critical care, oncology, sterile pharmaceuticals, aseptic manufacturing, sacramento, olympus partners, nivagen
## PAI Pharma Acquires Nexus
PAI Pharma has acquired Nexus Pharmaceuticals, expanding its portfolio of injectable medicines used in critical care, oncology and other hospital settings.
## Adds 20+ Hospital Products
The transaction adds more than 20 commercial hospital injectable products, customer relationships and development expertise to PAI’s growing sterile pharmaceutical business.
## Complementary Capabilities
Nexus specializes in complex injectable products, including therapies that have historically experienced supply shortages, complementing PAI’s ready-to-dose oral liquid products.
## Key takeaway

PAI Pharma acquired Nexus Pharmaceuticals to expand its hospital injectable product portfolio.